Organigram Global (OGI) Other Non-Current Assets (2023 - 2025)
Organigram Global (OGI) posted quarterly Other Non-Current Assets of $36.0 million for Q3 2025, up 20.59% year-on-year from $29.9 million in Q3 2024, and up 20.59% on a QoQ basis from $29.9 million in Q3 2024.
Organigram Global (OGI) Other Non-Current Assets (2023 - 2025) Analysis & Trends
Organigram Global (OGI) has reported Other Non-Current Assets for 3 consecutive years, with $36.0 million the latest figure, recorded in Q3 2025.
- Quarterly Other Non-Current Assets rose 20.59% year-over-year to $36.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $36.0 million (up 20.59% YoY) and the FY2025 annual result came in at $36.0 million, up 20.59% from the prior year.
- Other Non-Current Assets rose to $36.0 million in Q3 2025 per OGI's latest filing, from $29.9 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for OGI reached as high as $36.0 million in Q3 2025 and fell as low as $13.3 million in Q3 2023.
- A 3-year average of $26.4 million and a median of $29.9 million in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets surged 123.68% — and 2025, when it increased 20.59%.
- Year by year, Other Non-Current Assets stood at $13.3 million in 2023, then jumped by 123.68% to $29.9 million in 2024, then advanced by 20.59% to $36.0 million in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $36.0 million, $29.9 million, and $13.3 million for Q3 2025, Q3 2024, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 36.00 Mn |
| Sep 30, 2024 | 29.86 Mn |
| Sep 30, 2023 | 13.35 Mn |